Quarterly report pursuant to Section 13 or 15(d)

Statements of Cash Flows (unaudited)

v3.24.1.1.u2
Statements of Cash Flows (unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (3,134,262) $ (2,240,142)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 587,234 131,260
Increase (decrease) in cash resulting from changes in:    
Prepaid expenses and other current assets 94,424 174,848
Accounts payable (43,482) (3,831)
Accrued and other current liabilities (208,368) 288,232
Total adjustments to reconcile net loss to net cash used in operations 429,808 590,509
Net cash used in operating activities (2,704,454) (1,649,633)
Cash flows from financing activities:    
Proceeds from issuance of Common Stock and warrants, net of issuance costs 0 4,174,985
Proceeds from exercise of pre-funded warrants 0 153
Payment for fractional shares in reverse stock split 0 (40)
Net cash provided by financing activities 0 4,175,098
Net increase (decrease) in Cash and cash equivalents (2,704,454) 2,525,465
Cash and cash equivalents at beginning of period 7,438,135 6,241,294
Cash and cash equivalents at end of period 4,733,681 8,766,759
Non-cash financing activities:    
Issuance of abeyance shares (273) 0
Incremental fair value of March 2023 warrant modification $ 0 $ 144,765